Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2024-09-18 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The document does not contain any financial statements, detailed financial data, or report content. It is essentially an announcement of a meeting schedule, not a report or detailed presentation. The document length is 2527 characters, which is relatively short and fits the pattern of a regulatory announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate due to loss or misplacement by shareholders. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is a compliance notification about a specific corporate action related to share certificates, not a financial report, earnings release, or management discussion. It is not a report itself but an official regulatory communication to stock exchanges. The document length is short (2295 characters), and it is an intimation rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-12 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of a share certificate and the consequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The document is short (2307 characters) and serves as an intimation or notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, or audit information. It is not an announcement of voting results, capital changes, or insider dealings. The content fits best under a regulatory announcement category related to compliance and shareholder record updates. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-08-31 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation – August, 2024' and is addressed to stock exchanges and regulatory bodies under SEBI regulations. It contains detailed business model descriptions, strategy, revenue performance, manufacturing capabilities, and R&D information. The content is typical of an investor presentation focusing on financials, strategy, and market position. There is no indication that this is a full annual or quarterly report, audit report, earnings release, or any other regulatory filing. The document is not a brief announcement or a certification but a detailed presentation. Therefore, the appropriate classification is Investor Presentation (IP).
2024-08-30 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates to shareholders due to loss or misplacement of original certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which deals with share certificate matters. The content is an intimation or notification about share certificate issuance, not a financial report, management discussion, or any other type of report. It is a regulatory announcement related to share certificates and shareholder records. Given the nature of the document as an official notification to exchanges about share certificate duplication, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the schedule of an Investors / Analysts Meet. It is a notification to stock exchanges about upcoming investor meetings, without any financial data or detailed report content. The document length is 3519 characters, which is relatively short and primarily serves as an announcement. There is no financial statement, analysis, or detailed presentation included. Therefore, it is not an Annual Report, Earnings Release, or Investor Presentation. It is a regulatory announcement about a scheduled event, fitting best under Regulatory Filings (RNS).
2024-08-26 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.